2 unknown, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow Tosk, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690 TK-112690, Placebo - Mucositis | Phase 2 | Unknown | Tosk, Inc. | 24 | 2022-06-17 | 2023-08-14 |
| Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690 TK-112690, Placebo - Mucositis | Phase 2 | Unknown | Tosk, Inc. | 24 | 2022-06-15 | 2023-08-14 |
| Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690 TK-112690, Placebo TK-112690 - Mucositis | Phase 2 | Completed | Tosk, Inc. | 22 | 2019-05-15 | 2023-08-25 |
Mucositis (3) · Head and Neck Neoplasms (2) · Colorectal Neoplasms (1)
Therapeutics (1)
India (3)